The laboratory analyzes this parameter three times a week. Please expect a somewhat longer processing time.
Professionelle Probenentnahme vor Ort in der Apotheke
Einfache Kapillarblutentnahme innerhalb von 2 Minuten
Auswertung durch medizinisches Facharztlabor
Labor-Ergebnisse als PDF oder online
Beta-CrossLaps are fragments of type-I collagen that are released during bone resorption. The laboratory value measures the concentration of these markers in the blood and is used to assess bone resorption.
A Beta-CrossLaps test is recommended for: • Patients with suspected osteoporosis or increased bone resorption • Monitoring of patients under osteoporosis treatment (e.g. bisphosphonates, Denosumab) • Diagnosis of bone diseases such as Paget's disease or secondary osteoporosis • People with symptoms such as bone pain or frequent fractures
The test serves the diagnosis and monitoring of diseases associated with increased bone loss. It is an important marker for assessing the effectiveness of osteoporosis therapies.
An elevated beta-CrossLaps value indicates: • Increased bone loss in osteoporosis • Bone damage from tumors or metastases • Increased bone metabolism in hyperparathyroidism A low value is often an indication of successful treatment or low bone metabolism. Symptoms with elevated values can be: • Bone pain • Increased fracture risk
The testing should be carried out in the morning fasting, as Beta-CrossLaps exhibit diurnal variations.
• Beta-CrossLaps are a specific marker for bone breakdown and are often measured together with other parameters such as Ostase. • Chronic diseases that affect metabolism (e.g. thyroid disorders) can alter the values. • Regular monitoring in osteoporosis patients helps to adjust the therapy.